Sientra narrows losses in first quarter report
Goleta-based breast implant company Sientra continued to cut its losses, losing $11.4 million in the first quarter of 2017, down from $11.9 million for the same period the year prior. “I am pleased with our first quarter performance, which was in line or above our expectations,” said Jeffrey Nugent, chairman and CEO. “In the first Read More →
Read More →MindBody revenue soars but net loss continues
San Luis Obispo-based MindBody reported $42.2 million in first quarter revenue, a 32 percent increase from a year ago during the same period, but the company still reported a net loss. The GAAP net loss in the first quarter of 2017 was $3.9 million, down from $6.6 million during the first quarter of 2016. The Read More →
Read More →Amgen to provide rebates for Repatha patients who have heart attack or stroke
Thousand Oaks-based Amgen announced on May 2 that it has reached a “first-of-its-kind contract” with health care company Harvard Pilgrim. The contract provides Harvard Pilgrim with a rebate for the cost of Repatha for any eligible patient who has a heart attack or stroke while on Repatha. “Amgen is committed to combating cardiovascular disease, one Read More →
Read More →Amgen revenues fall but profits increase
Thousand Oaks-based biotech giant Amgen’s total revenues decreased by 1 percent to $5.5 billion during the first quarter of 2017, compared to the same period a year ago, according to an earnings report April 26. The drop was related to the plunge in sales of Enbrel, its rheumatoid arthritis drug. Sales decreased 15 percent due Read More →
Read More →Dubroff: East Ventura County should focus on creating a biotech cluster
When the Business Times broke the story that Amgen was cutting roughly 500 support and operations jobs at its sprawling Thousand Oaks campus, there were gasps — and sighs of relief. Gasps because the world’s largest biotechnology company is the economic engine for the Conejo Valley, East Ventura County and, for that matter, a big Read More →
Read More →